Tracleer May Delay Onset of Pulmonary Arterial Hypertension (PAH) in Scleroderma Patients

​Early treatment with Tracleer (bosentan) may delay the development of pulmonary arterial hypertension (PAH) in people with scleroderma, according to a study that compared patients who had never used this medicine with those taking it for digital ulcers.

Click here for more >>

15 Best Superfoods for Fall

The weather is getting cooler (for most of us), but your produce choices are heating up!  These superfoods are either hitting their peak in the garden or can easily be found at your local farmers market or grocery store.

Click here for more >>

Video: Skin Care and Wound Management in Systemic Sclerosis

We are happy to announce that select videos from the 2016 National Conference are now available online.  In this session, Alexandria Crowe, R.N., helps patients understand what is happening to their skin as Systemic Sclerosis progresses. She also includes evidence-based therapies to consider.  This video and more can be found on our YouTube channel.  We will continue to post more videos as them become available.

Click here to watch the entire session >>

Reata Pharmaceuticals, Inc. Enrolls First Patient in Phase 3 CATALYST Trial of Bardoxolone Methyl in Connective Tissue Disease-Associated with Pulmonary Arterial Hypertension (CTD-PAH)

Reata Pharmaceuticals, Inc. has enrolled the first patient into its Phase 3 trial (CATALYST) to evaluate the efficacy and safety of bardoxolone methyl in patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH).

Click here to read more >>